Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Fegan

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|March 2, 2005
Genetic screening for hemochromatosis: a cautionary taleJane Starczynski, Laura Hooper, Nageeb Ali, et al.
Haematologica|July 2, 2013
Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cellsRyan Wong, Chris Pepper, Paul Brennan, et al.
Journal of Vascular Surgery|January 18, 2006
The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplastySimon D Hobbs, Tim Marshall, Chris Fegan, et al.
Journal of Vascular Surgery|September 4, 2007
The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysmsSimon D Hobbs, Paul Haggart, Chris Fegan, et al.
Journal of Vascular Surgery|January 11, 2007
The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trialSimon D Hobbs, Tim Marshall, Chris Fegan, et al.
Oncotarget|January 13, 2017
Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptorChris Pepper, Henry Tu, Paul Morrill, et al.
Immunology|October 7, 2014
CD8<sup>+</sup> T-cell recognition of a synthetic epitope formed by t-butyl modificationReiss A Reid, James E Redman, Pierre Rizkallah, et al.
Blood|June 22, 2010
The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoireBatoul Pourgheysari, Rachel Bruton, Helen Parry, et al.
Cell Cycle (Georgetown, Tex.)|April 16, 2003
Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridolChris Pepper, Alun Thomas, Terry Hoy, et al.
Leukemia|February 24, 2019
Telomere fusions associate with coding sequence and copy number alterations in CLLLaura Escudero, Kez Cleal, Kevin Ashelford, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|March 2, 2005
Genetic screening for hemochromatosis: a cautionary taleJane Starczynski, Laura Hooper, Nageeb Ali, et al.
Haematologica|July 2, 2013
Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cellsRyan Wong, Chris Pepper, Paul Brennan, et al.
Journal of Vascular Surgery|January 18, 2006
The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplastySimon D Hobbs, Tim Marshall, Chris Fegan, et al.
Journal of Vascular Surgery|September 4, 2007
The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysmsSimon D Hobbs, Paul Haggart, Chris Fegan, et al.
Journal of Vascular Surgery|January 11, 2007
The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trialSimon D Hobbs, Tim Marshall, Chris Fegan, et al.
Oncotarget|January 13, 2017
Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptorChris Pepper, Henry Tu, Paul Morrill, et al.
Immunology|October 7, 2014
CD8<sup>+</sup> T-cell recognition of a synthetic epitope formed by t-butyl modificationReiss A Reid, James E Redman, Pierre Rizkallah, et al.
Blood|June 22, 2010
The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoireBatoul Pourgheysari, Rachel Bruton, Helen Parry, et al.
Cell Cycle (Georgetown, Tex.)|April 16, 2003
Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridolChris Pepper, Alun Thomas, Terry Hoy, et al.
Leukemia|February 24, 2019
Telomere fusions associate with coding sequence and copy number alterations in CLLLaura Escudero, Kez Cleal, Kevin Ashelford, et al.
Pageof 6